Assertio Holdings, Inc.

NasdaqCM:ASRT 株式レポート

時価総額:US$89.8m

Assertio Holdings 過去の業績

過去 基準チェック /06

Assertio Holdingsの収益は年間平均-7.7%の割合で減少していますが、 Pharmaceuticals業界の収益は年間 増加しています。収益は年間1.2% 2.6%割合で 減少しています。

主要情報

-7.7%

収益成長率

37.5%

EPS成長率

Pharmaceuticals 業界の成長6.0%
収益成長率-2.6%
株主資本利益率-52.5%
ネット・マージン-54.5%
前回の決算情報30 Sep 2024

最近の業績更新

Recent updates

Little Excitement Around Assertio Holdings, Inc.'s (NASDAQ:ASRT) Revenues As Shares Take 25% Pounding

Nov 15
Little Excitement Around Assertio Holdings, Inc.'s (NASDAQ:ASRT) Revenues As Shares Take 25% Pounding

Is Assertio Holdings (NASDAQ:ASRT) Using Debt Sensibly?

Sep 25
Is Assertio Holdings (NASDAQ:ASRT) Using Debt Sensibly?

Assertio Holdings, Inc. (NASDAQ:ASRT) Not Doing Enough For Some Investors As Its Shares Slump 30%

Aug 19
Assertio Holdings, Inc. (NASDAQ:ASRT) Not Doing Enough For Some Investors As Its Shares Slump 30%

There's No Escaping Assertio Holdings, Inc.'s (NASDAQ:ASRT) Muted Revenues Despite A 36% Share Price Rise

Jul 04
There's No Escaping Assertio Holdings, Inc.'s (NASDAQ:ASRT) Muted Revenues Despite A 36% Share Price Rise

Assertio Holdings, Inc. (NASDAQ:ASRT) Stock Catapults 29% Though Its Price And Business Still Lag The Industry

May 07
Assertio Holdings, Inc. (NASDAQ:ASRT) Stock Catapults 29% Though Its Price And Business Still Lag The Industry

Does Assertio Holdings (NASDAQ:ASRT) Have A Healthy Balance Sheet?

Apr 18
Does Assertio Holdings (NASDAQ:ASRT) Have A Healthy Balance Sheet?

Improved Revenues Required Before Assertio Holdings, Inc. (NASDAQ:ASRT) Stock's 26% Jump Looks Justified

Mar 13
Improved Revenues Required Before Assertio Holdings, Inc. (NASDAQ:ASRT) Stock's 26% Jump Looks Justified

We Think Assertio Holdings (NASDAQ:ASRT) Can Stay On Top Of Its Debt

Apr 26
We Think Assertio Holdings (NASDAQ:ASRT) Can Stay On Top Of Its Debt

Is There An Opportunity With Assertio Holdings, Inc.'s (NASDAQ:ASRT) 23% Undervaluation?

Mar 02
Is There An Opportunity With Assertio Holdings, Inc.'s (NASDAQ:ASRT) 23% Undervaluation?

Assertio Holdings Looks Good To Rebound After Recent Price Plunge

Sep 07

Assertio Holdings: Substantial Upside

Aug 21

Assertio Therapeutics Q2 2022 Earnings Preview

Aug 05

Assertio Holdings: Management Still Swimming Against The Tide

Jun 10

Assertio's Phenomenal Turnaround

May 19

Assertio Holdings: Recent Breakout To Lead To Sustained Gains

Apr 07

Assertio's Digital Strategy Looks To Be Paying Off

Jan 21

Assertio shares rise on Q1 revenue strength, provides FY forecast

May 07

収支内訳

Assertio Holdings の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

NasdaqCM:ASRT 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
30 Sep 24126-68794
30 Jun 24132-345814
31 Mar 24142-333714
31 Dec 23152-332703
30 Sep 23169-186602
30 Jun 2316898551
31 Mar 2316297550
31 Dec 22156110480
30 Sep 2213926350
30 Jun 2213025410
31 Mar 221213430
31 Dec 21111-1460
30 Sep 21110-30690
30 Jun 21119-44752
31 Mar 21114-65903
31 Dec 20108-281044
30 Sep 20135-19610610
30 Jun 20156-18311610
31 Mar 20192-1621139
31 Dec 19230-21711010
30 Sep 19157-491117
30 Jun 19180-41087
31 Mar 19186-111168
31 Dec 18256371208
30 Sep 18364281437
30 Jun 18381-361607
31 Mar 18419-4217910
31 Dec 17381-10220314
30 Sep 17410-11420322
30 Jun 17425-11120530
31 Mar 17442-9520632
31 Dec 16456-8920533
30 Sep 16443-7519430
30 Jun 16437-7419224
31 Mar 16415-8519722
31 Dec 15343-7617918
30 Sep 154265017013
30 Jun 153736814810
31 Mar 153461021237
31 Dec 143901321217
30 Sep 14236791197
30 Jun 14222791197
31 Mar 14185671127
31 Dec 13134431058

質の高い収益: ASRTは現在利益が出ていません。

利益率の向上: ASRTは現在利益が出ていません。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: ASRTは利益が出ておらず、過去 5 年間で損失は年間7.7%の割合で増加しています。

成長の加速: ASRTの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: ASRTは利益が出ていないため、過去 1 年間の収益成長をPharmaceuticals業界 ( 54.6% ) と比較することは困難です。


株主資本利益率

高いROE: ASRTは現在利益が出ていないため、自己資本利益率 ( -52.47% ) はマイナスです。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘